Ertugliflozin L-pyroglutamic acid
CAS No. 1210344-83-4
Ertugliflozin L-pyroglutamic acid( PF-04971729 L-pyroglutamic acid )
Catalog No. M26680 CAS No. 1210344-83-4
Ertugliflozin L-pyroglutamic acid is a selective and orally active hSGLT2 inhibitor with an IC50 of 0.877 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 35 | In Stock |
|
| 10MG | 50 | In Stock |
|
| 25MG | 74 | In Stock |
|
| 50MG | 87 | In Stock |
|
| 100MG | 129 | In Stock |
|
| 200MG | 188 | In Stock |
|
| 500MG | 322 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameErtugliflozin L-pyroglutamic acid
-
NoteResearch use only, not for human use.
-
Brief DescriptionErtugliflozin L-pyroglutamic acid is a selective and orally active hSGLT2 inhibitor with an IC50 of 0.877 nM.
-
DescriptionErtugliflozin L-pyroglutamic acid is a selective and orally active hSGLT2 inhibitor with an IC50 of 0.877 nM. Ertugliflozin L-pyroglutamic acid can be used for studies about the treatment of type 2 diabetes mellitus.(In Vitro):Ertugliflozin L-pyroglutamic acid demonstrated >2000-fold selectivity for SGLT2 over SGLT.(In Vivo):The oral administration of Ertugliflozin L-pyroglutamic to rats acid showed concentration-dependent glucosuria.
-
In Vitro——
-
In Vivo——
-
SynonymsPF-04971729 L-pyroglutamic acid
-
PathwayOthers
-
TargetOther Targets
-
RecptorCaspase-3
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1210344-83-4
-
Formula Weight566
-
Molecular FormulaC27H32ClNO10
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : ≥ 125 mg/mL (220.85 mM)
-
SMILESOC(=O)[C@@H]1CCC(=O)N1.CCOc1ccc(Cc2cc(ccc2Cl)[C@]23OC[C@](CO)(O2)[C@@H](O)[C@H](O)[C@H]3O)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
pTH (73-84) (human)
pTH (73-84) (human) is a polypeptide that can be found by peptide screening. Peptide screening is a research tool that pools active peptides primarily by immunoassay. Peptide screening can be used for protein interaction, functional analysis, epitope screening, especially in the field of agent research and development.
-
Teneligliptin hydrob...
Teneligliptin is a novel, potent, and long-lasting dipeptidyl peptidase-4 inhibitor; competitively inhibited human plasma, rat plasma, and human recombinant DPP-4 in vitro, with IC50 values of approximately 1 nM.
-
Myosin Kinase Inhibi...
Myosin light chain kinase fragment 11-19 amide (MLCK(11-19) amide) is a substrate-specific peptide inhibitor of MLCK. Myosin light chain kinase fragment 11-19 amide inhibits hypotonicity-induced Ca2+ entry. Myosin light chain kinase fragment 11-19 amide can be used in the research of human cervical cancer.
Cart
sales@molnova.com